AtriCure Inc. (ATRC) PT Raised to $52 at Needham After EBITDA Beats Positive Revenue Preannouncement
Tweet Send to a Friend
Needham & Company analyst, Mike Matson, raised the price target on AtriCure Inc. (NASDAQ: ATRC) to $52.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
